- Home
- TIL vs TBI Comparison
TIL vs TBI Comparison
Compare TIL & TBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- TBI
- Stock Information
- Founded
- TIL 2018
- TBI 1985
- Country
- TIL United States
- TBI United States
- Employees
- TIL N/A
- TBI N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- TBI Professional Services
- Sector
- TIL Health Care
- TBI Consumer Discretionary
- Exchange
- TIL Nasdaq
- TBI Nasdaq
- Market Cap
- TIL 177.1M
- TBI 165.9M
- IPO Year
- TIL 2021
- TBI 1996
- Fundamental
- Price
- TIL $17.27
- TBI $4.99
- Analyst Decision
- TIL Strong Buy
- TBI Buy
- Analyst Count
- TIL 5
- TBI 1
- Target Price
- TIL $100.67
- TBI $8.00
- AVG Volume (30 Days)
- TIL 97.5K
- TBI 266.9K
- Earning Date
- TIL 11-13-2025
- TBI 11-03-2025
- Dividend Yield
- TIL N/A
- TBI N/A
- EPS Growth
- TIL N/A
- TBI N/A
- EPS
- TIL N/A
- TBI N/A
- Revenue
- TIL N/A
- TBI $1,534,863,000.00
- Revenue This Year
- TIL N/A
- TBI $2.21
- Revenue Next Year
- TIL N/A
- TBI $6.18
- P/E Ratio
- TIL N/A
- TBI N/A
- Revenue Growth
- TIL N/A
- TBI N/A
- 52 Week Low
- TIL $10.80
- TBI $3.45
- 52 Week High
- TIL $44.50
- TBI $9.05
- Technical
- Relative Strength Index (RSI)
- TIL 40.68
- TBI 32.69
- Support Level
- TIL $17.44
- TBI $5.28
- Resistance Level
- TIL $20.11
- TBI $5.98
- Average True Range (ATR)
- TIL 1.29
- TBI 0.27
- MACD
- TIL -0.00
- TBI -0.02
- Stochastic Oscillator
- TIL 1.61
- TBI 0.98
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About TBI TrueBlue Inc.
TrueBlue Inc is a provider of staffing and workforce management solutions. Its reportable segments include PeopleReady offers industrial staffing services. PeopleManagement offers contingent and productivity-based on-site industrial staffing services and PeopleScout offers recruitment process outsourcing, talent advisory services, and managed service provider services. It generates maximum revenue from the PeopleReady segment.